VAI Folio 2019

BUT IT’S NOT JUST OUR MISSION
THAT SETS US APART. IT’S HOW WE
MAKE IT REAL.
“This place is a miracle. As
a survivor and a person
whose family has been
affected by cancer, I am
well aware that we need
better treatments and
cures. I also know that if
we can continue to support
research with discipline
and tenacity, we will one
day find them.”
Dr. Juan Olivarez
Donor & Trustee
WHAT WE STUDY
Alzheimer’s disease
Metabolism
Diabetes Depression
Multiple system atrophy Neurofibromatosis type 1
Blood cancers Prostate cancer
Parkinson’s disease
Epigenetics
Aging Cancer
Sarcoma
Ovarian cancer
Dementia with Lewy bodies Osteoarthritis Breast cancer
Heart disease
Osteoporosis
Bone diseases
RESEARCH BY THE NUMBERS
32
8
3
2
3
3
Labs
Cores
Structural biology
Colorectal cancer
Pancreatic cancer
Members of National Academy of Sciences
Members of American Academy
of Arts and Sciences
Fellows of American Association
for the Advancement of Science
Fellows of American Association
for Cancer Research Academy
GRADUATE SCHOOL BY THE NUMBERS
5.3
3
3
68 %
75 %
YEARS AVERAGE TIME TO Ph.D.
SEVEN-WEEK LABORATORY ROTATIONS
DURING FIRST TWO SEMESTERS
YEARS OF DOCTORAL CANDIDATE THESIS RESEARCH
IN A FACULTY MENTOR’S LAB
Ph.D. GRADUATION RATE
TOTAL GRADUATION RATE (Ph.D. and M.D.)
WHERE WE COLLABORATE
Van Andel Institute has employees from more than 40 countries
and collaborates with scientists around the world.
CATALYTIC COLLABORATIONS
Through collaboration with key philanthropic,
academic and pharmaceutical industry partners,
we are working to translate what we learn in our
laboratories into clinical trials to develop new
treatments for cancer and Parkinson’s disease
patients.
VAN ANDEL INSTITUTE–STAND UP TO CANCER
EPIGENETICS DREAM TEAM
12+
TRIALS
470+
15+
CLINICAL
SITES
PATIENTS ENROLLED
VAN ANDEL INSTITUTE–CURE PARKINSON’S TRUST
INTERNATIONAL LINKED CLINICAL TRIALS INITIATIVE
15 TRIALS 10
TRIALS IN
DEVELOPMENT
850+ PATIENTS ENROLLED 7